UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Journal of cancer research and clinical oncology, 2022-08, Vol.148 (8), p.2115-2125

2022

Volltextzugriff (PDF)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Journal of cancer research and clinical oncology, 2019-10, Vol.145 (10), p.2541-2546

2019

Volltextzugriff (PDF)

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.821-833

2021

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer

Journal of cancer research and clinical oncology, 2019-12, Vol.145 (12), p.3105-3114

2019

Volltextzugriff (PDF)

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.945-954

2018

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

Journal of cancer research and clinical oncology, 2020-04, Vol.146 (4), p.1065-1077

2020

Volltextzugriff (PDF)

GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

Journal of cancer research and clinical oncology, 2022-10, Vol.148 (10), p.2643-2652

2022

Volltextzugriff (PDF)

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1905-1915

2023

Volltextzugriff (PDF)

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Journal of cancer research and clinical oncology, 2019-06, Vol.145 (6), p.1613-1623

2019

Volltextzugriff (PDF)

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials

Journal of cancer research and clinical oncology, 2021-08, Vol.147 (8), p.2407-2420

2021

Volltextzugriff (PDF)

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

Journal of cancer research and clinical oncology, 2022-01, Vol.148 (1), p.225-236

2022

Volltextzugriff (PDF)

Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1691-1702

2023

Volltextzugriff (PDF)

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

Journal of cancer research and clinical oncology, 2020-11, Vol.146 (11), p.3003-3012

2020

Volltextzugriff (PDF)

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3039-3046

2022

Volltextzugriff (PDF)

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3183-3189

2022

Volltextzugriff (PDF)

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

Journal of cancer research and clinical oncology, 2022-05, Vol.148 (5), p.1123-1135

2022

Volltextzugriff (PDF)

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3103-3108

2022

Volltextzugriff (PDF)

Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes

Journal of cancer research and clinical oncology, 2020-09, Vol.146 (9), p.2427-2433

2020

Volltextzugriff (PDF)

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1195-1209

2023

Volltextzugriff (PDF)

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3191-3202

2022

Volltextzugriff (PDF)

Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3117-3123

2022

Volltextzugriff (PDF)

Application of four nutritional risk indexes in perioperative management for esophageal cancer patients

Journal of cancer research and clinical oncology, 2021-10, Vol.147 (10), p.3099-3111

2021

Volltextzugriff (PDF)

Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1863-1872

2023

Volltextzugriff (PDF)

Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3047-3059

2022

Volltextzugriff (PDF)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

Journal of cancer research and clinical oncology, 2022-09, Vol.148 (9), p.2427-2435

2022

Volltextzugriff (PDF)

1 – 25 von 13.883

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.589)
Mit Volltextzugriff
(13.384)

Publikationsform

Artikel
(13.879)
Newsletter-Artikel
(4)

Sprache

Englisch
(13.587)
Französisch
(290)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13.238)
Life Sciences & Biomedicine
(13.230)
Oncology
(12.824)
Humans
(8.923)
Medicine
(6.703)
Medicine & Public Health
(6.604)
Female
(6.242)
Male
(5.688)
Middle Aged
(5.270)
Patients
(4.698)
Original Article
(4.649)
Aged
(4.606)
Clinical Trials
(4.218)
Adult
(3.943)
Cancer Research
(3.479)
Chemotherapy
(3.453)
Original Research
(3.391)
Original
(3.360)
Cancer
(3.107)
Tumors
(2.846)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(9.065)
Journals@Ovid
(7.846)
SpringerLink_现刊
(7.082)
EZB Electronic Journals Library
(6.971)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(6.548)
IngentaConnect
(6.011)
Wiley Online Library Journals
(3.181)
IngentaConnect Journals
(1.823)
NUS Single-Journal Subscriptions
(1.340)
Taylor & Francis Journals
(916)
Nature Journals Online
(712)
Nexis Uni
(702)
Springer Book Series
(351)
SAGE Journals
(329)
Wiley Online Library Full Collection 2018
(208)
BMJ journals (British Medical Journal and others)
(184)
JSTOR
(171)
Applied Social Sciences Index & Abstracts (ASSIA)
(158)
Taylor & Francis:Master (3349 titles)
(82)
Thieme - Connect here FIRST to enable access
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany

Application of four nutritional risk indexes in perioperative management for esophageal cancer patients

Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands

Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

Suchergebnisse filtern